Concepedia

Samuel J. Dominianni

SJ

Statistics

Publications

9

Citations

313

H-Index

9

Active since

1965

Affiliations

Eli Lilly (United States)(Current)

Ligand Pharmaceuticals (United States)

Samuel J. Dominianni is an author at Eli Lilly (United States) specializing in organic chemistry, pharmacology, and medicinal chemistry.

Publications per year

1965–2004

9

Publications

9

Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids:  A New Class of Dual PPARα/γ Agonists

Dawn A. Brooks, Garret J. Etgen, Christopher J. Rito et al. · Journal of Medicinal Chemistry · 2001 · 68 citations · Full text

, , +13

Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist

Yanping Xu, Daniel Mayhugh, Ashraf Saeed et al. · Journal of Medicinal Chemistry · 2003 · 61 citations · Full text

, , +13

Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides

Samuel J. Dominianni, Terence T. Yen · Journal of Medicinal Chemistry · 1989 · 55 citations

, , +11

Design and Synthesis of α-Aryloxy-α-methylhydrocinnamic Acids:  A Novel Class of Dual Peroxisome Proliferator-Activated Receptor α/γ Agonists

Yanping Xu, Christopher J. Rito, Garret J. Etgen et al. · Journal of Medicinal Chemistry · 2004 · 44 citations · Full text

, , +14

Synthesis of 5-(tert-alkyl)resorcinols

Samuel J. Dominianni, Charles W. Ryan, Chris DeArmitt · The Journal of Organic Chemistry · 1977 · 31 citations

, , +5

1–5 of 9